PXSLY:Pharmaxis Ltd - Stock Price Quote and Dividend Data

PXSLY STOCK PRICE LATEST CLOSE

$0.88

EXCHANGE

OTCBB

PXSLY

Pharmaxis Ltd Dividend Information

Projected 12 Month Dividend Yield0.00%
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
PXSLY

Pharmaxis Ltd Stock Price Information

PXSLY Stock Price Latest Close$0.88
52-Week Low/High Stock Price$0.62 - $1.47
Percent Held by Institutions0.00%
Revenue$13,029,000
Net Income$-13,943,000
Cash Flow$-13,284,000
EPS0.00%
Market Cap$11,410,080
PE Ratio0
PE Ratio to Industry41%
Debt-Equity Ratio18.00%
Debt-Equity to Industry1.82%
Total Return Last 12 Months-9.28%
Total Return Last 3 Years-76.09%
Total Return Last 5 Years-71.05%
Latest Trade DateMay. 21, 2021
PXSLY

Pharmaxis Ltd Annual Stock Dividends

No Data available for Payment History.

PXSLY

Pharmaxis Ltd Dividend Payment History

No dividends retrieved for PXSLY
PXSLY

Pharmaxis Ltd Other Dividend Details

Pharmaxis is a pharmaceutical research company. Co.'s product pipeline includes Semicarbazide-Sensitive Amine Oxidase for Non-Alcoholic Steatohepatitis (NASH) and diabetic retinopathy; Lysyl Oxidase Like Inhibitors targeting fibrotic diseases including NASH, pulmonary fibrosis, kidney fibrosis and cardiac fibrosis; and Lysyl Oxidase Inhibitors targeting severe fibrotic indications including scarring and some cancers. Co.'s products include Bronchitol®, an inhaled dry powder for the treatment of cystic fibrosis and is marketed in Europe, Russia and Australia; and Aridol®, a lung function test for asthma and is approved and sold in the United States, Europe, Australia and Asia.

Web Sitewww.pharmaxis.com.au
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Pharmaxis Ltd Dividend Stock News and Updates

May. 21, 2021PXSLY STOCK PRICE DECREASE: Pharmaxis Ltd on 05-21-2021 decreased stock price > 10% from $1.47 to $0.95

May. 19, 2021PXSLY STOCK PRICE INCREASE: Pharmaxis Ltd on 05-19-2021 increased stock price > 10% from $0.94 to $1.47

May. 19, 2021PXSLY STOCK PRICE 52 WEEK HIGH: Pharmaxis Ltd on 05-19-2021 hit a 52 week high of $1.47

Apr. 21, 2021PXSLY STOCK PRICE DECREASE: Pharmaxis Ltd on 04-21-2021 decreased stock price > 10% from $1.00 to $0.89

Feb. 23, 2021STOCK PRICE DECREASE: Pharmaxis Ltd (OTCBB: PXSLY) on 02-23-2021 decreased stock price > 10% from $1.13 to $0.94

Feb. 11, 2021STOCK PRICE INCREASE: Pharmaxis Ltd (OTCBB: PXSLY) on 02-11-2021 increased stock price > 10% from $1.01 to $1.13

Jan. 14, 2021STOCK PRICE INCREASE: Pharmaxis Ltd (OTCBB: PXSLY) on 01-14-2021 increased stock price > 10% from $1.00 to $1.15

Nov. 03, 2020STOCK PRICE INCREASE: Pharmaxis Ltd (OTCBB: PXSLY) on 11-03-2020 increased stock price > 10% from $1.00 to $1.10

Sep. 09, 2020CLOSE PRICE DECREASE: Pharmaxis Ltd (OTCBB: PXSLY) on 09-09-2020 decreased close price > 10% from $1.14 to $0.95

Sep. 02, 2020CLOSE PRICE INCREASE: Pharmaxis Ltd (OTCBB: PXSLY) on 09-02-2020 increased close price > 10% from $0.86 to $1.14

More Pharmaxis Ltd Dividend News
Pharmaceuticals Dividend Stock News and Updates

Apr. 11, 2025NTHI STOCK PRICE DECREASE: NeOnc Technologies Holdings Inc on 04-11-2025 decreased stock price > 10% from $10.00 to $9.00

Apr. 11, 2025SION STOCK PRICE DECREASE: Sionna Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $8.88 to $7.66

Apr. 11, 2025MTSR STOCK PRICE DECREASE: Metsera Inc on 04-11-2025 decreased stock price > 10% from $15.27 to $13.08

Apr. 11, 2025CYTOF STOCK PRICE DECREASE: Altamira Therapeutics Ltd on 04-11-2025 decreased stock price > 10% from $0.09 to $0.06

Apr. 11, 2025DWTX STOCK PRICE DECREASE: Dogwood Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $3.30 to $2.94

Apr. 11, 2025TRVN STOCK PRICE DECREASE: Com Par $0.001/Trevena Inc on 04-11-2025 decreased stock price > 10% from $1.36 to $1.20

Apr. 11, 2025OSTX STOCK PRICE DECREASE: OS Therapies Inc on 04-11-2025 decreased stock price > 10% from $1.34 to $1.12

Apr. 11, 2025RGBPP STOCK PRICE DECREASE: Pfd Ser A (New)/Regen BioPharma Inc on 04-11-2025 decreased stock price > 10% from $0.06 to $0.05

Apr. 11, 2025ALMS STOCK PRICE DECREASE: Alumis Inc on 04-11-2025 decreased stock price > 10% from $8.04 to $6.83

Apr. 11, 2025CTNM STOCK PRICE DECREASE: Cl A/Contineum Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $4.62 to $4.13

More Pharmaceuticals Dividend News
X
Search Dividend Investor